As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...

City work crews were observed dismantling a section of a dedicated bike lane along Massachusetts Avenue in Dorchester between South Bay Mall and Edward Everett Square on Monday, March 10, 2025. The ...

Theralase® will be hosting a conference call on March 19th at 11:00 am ET, which will include a presentation of the financial ...

TAGRISSO has become a standard treatment due to its strong efficacy in both first-line and adjuvant settings. The growing prevalence of EGFR mutations, a rise in lung cancer diagnoses, and broader ...

The Global Metal Fabrication Equipment Market is valued at approximately USD 68.36 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of over 3.90% from 2024 to 2032.

Sino-American biopharma Ascentage Pharma has announced that olverembatinib has been granted Breakthrough Therapy Designation ...

In the Georgia General Assembly, Republican battles will determine culture wars, other battles this legislative session.

(Alliance News) - Ryanair Holdings PLC on Friday said it will now allow non-EU nationals to buy ordinary shares, ending a prohibition that has also applied to UK nationals since 2021.

Ascentage Pharma’s olverembatinib gets China NMPA’s BTD to treat Philadelphia chromosome-positive acute lymphoblastic leukemia: Rockville Friday, March 7, 2025, 11:00 Hrs [IST ...

DelveInsight's "TEPMETKO Market Size, Forecast, and Market Insight Report" highlights the details around TEPMETKO, a kinase ...